OKYO Pharma Limited (OKYO)

AI Score

Unlock

1.12

-0.09 (-7.44%)

At close: Apr 04, 2025, 1:21 PM

OKYO Pharma Balance Sheet Statement

Chart Mode

Financials in USD. Fiscal year is April - March.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012	FY 2011	FY 2010	FY 2009	FY 2008
Period Ending	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017	Mar 31, 2016	Mar 31, 2015	Mar 31, 2014	Mar 31, 2013	Mar 31, 2012	Mar 31, 2011	Mar 31, 2010	Mar 31, 2009	Mar 31, 2008
Cash & Equivalents	826.85K	4.05M	2.7M	6.89M	234.96K	627.56K	n/a	n/a	5.13M	6.47M	11.82M	14.34M	17.03M	16.07M	26.64M	5.38M	17.97M
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	16.86M	n/a	n/a	n/a	n/a	n/a	n/a	27.49M	25.25M	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-0.00	n/a	n/a	0.00	n/a
Other Long-Term Assets	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	1.00	n/a	1.00	1.00	-17.03M	n/a	n/a	-5.38M	-17.97M
Receivables	580.94K	n/a	n/a	n/a	326.22K	111.36K	47.65	n/a	n/a	n/a	260.65K	1.95K	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	-1.49K	34.00	-792.07	125.90	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	n/a	n/a	n/a	76.28K	263.09K	85.46K	n/a	n/a	113.79K	159.64K	156.59K	153.39K	n/a	n/a	7.54K	8.6K	71.44K
Total Current Assets	1.54M	5.2M	4.3M	6.99M	566.73K	758.75K	47.65	16.86M	5.37M	6.79M	12.19M	14.58M	17.47M	16.09M	54.13M	30.65M	18.04M
Property-Plant & Equipment	3.35K	7.22K	5.22K	104.64K	30.66K	1.1K	n/a	n/a	17.16M	17.31M	19.54M	11.39M	4.46M	n/a	n/a	6.9M	9.56M
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	9.65M	9.94M	15.48M	19.23M	20.26M	n/a	n/a	717.73K	n/a
Total Long-Term Assets	3.35K	7.22K	5.22K	104.64K	30.66K	1.1K	n/a	n/a	26.81M	27.26M	35.02M	30.62M	24.73M	16.07M	26.64M	7.62M	9.56M
Total Assets	1.54M	5.2M	4.3M	7.09M	597.4K	759.86K	n/a	n/a	32.18M	34.05M	47.21M	45.2M	42.2M	16.09M	54.13M	38.27M	27.6M
Account Payables	6.13M	1.02M	517.67K	210.99K	479.97K	381.76K	n/a	141.79K	124.12K	120.37K	123.04K	73.64K	493.25K	41.78K	79.87K	85.96K	144.86K
Deferred Revenue	n/a	n/a	n/a	n/a	-0.11	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	1.8M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	n/a	1.71M	323.06K	1.46M	21.58K	-1.13K	87.59K	1.00	16.95K	29.62K	-98.99K	66.39K	255.62K	36.96K	n/a	n/a	n/a
Total Current Liabilities	7.42M	7.26M	1.35M	1.71M	710.66K	426.72K	n/a	n/a	181.34K	151.07K	247.95K	183.32K	832.89K	78.74K	79.87K	85.96K	144.86K
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	n/a	n/a	n/a	64.61K	26.54K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Liabilities	7.42M	7.26M	1.35M	1.77M	737.2K	426.72K	n/a	n/a	181.34K	151.07K	247.95K	183.32K	832.89K	78.74K	79.87K	85.96K	144.86K
Total Debt	n/a	2.22M	n/a	98.76K	31.62K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock	n/a	131.39M	123.98M	111.63M	n/a	89.22M	n/a	n/a	95.12M	98.02M	n/a	90.6M	n/a	n/a	n/a	n/a	n/a
Retained Earnings	-142.52M	-125.7M	-112.43M	-106M	-85.88M	-88.97M	n/a	n/a	-64.71M	-65.92M	-66M	-48.16M	-29.65M	-9.54M	28.96M	12.19M	-2.97M
Comprehensive Income	-11.31M	-11.45M	-11.01M	12.82M	2.22M	82.12K	n/a	n/a	-276.54K	n/a	157.21K	n/a	n/a	n/a	n/a	n/a	n/a
Shareholders Equity	-5.88M	-2.05M	2.95M	5.32M	-139.8K	333.14K	n/a	n/a	32M	33.9M	46.96M	45.02M	41.34M	16.01M	54.05M	38.18M	27.46M
Total Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	16.86M	n/a	n/a	n/a	n/a	-0.00	n/a	27.49M	25.25M	n/a